Anovo received clearance for use in single-site, abdominal access across ventral hernia repair. The clearance complements Anovo’s existing approvals for natural orifice laparoscopic-assisted transvaginal benign gynecology procedures.
Momentis designed Anovo as a single-port robotics platform and clearance makes it the first such system cleared for this indication. The company says procedures performed through a single port with multiple flexible instruments could potentially result in less invasive and less traumatic outcomes for the tissue at point of entry.
The Anovo system, a small, portable robotic system, enables this. Its miniature humanoid-shaped robotic arms provide human-level dexterity, the company says. Momentis also developed it with multi-planar flexibility and 360 degrees of articulation. Its biomimetic instruments replicate the motions and capabilities of a surgeon’s arms, with shoulder, elbow and wrist joints.
Dr. Fred Moll, a pioneer in surgical robotics and board member at Momentis, believes “the future of soft tissue robotics is flexible instruments.” He called Momentis’ technology “clearly differentiating” and capable of having an “immediate impact” on general surgery.
“Leveraging the clinical achievements of our Anovo platform in gynecology and the connections we established with leading medical centers worldwide, we have seized the opportunity to expand to general surgery for our groundbreaking technology. Due to its size and mobility, our system can be used both in hospitals and outpatient settings, where most hernia surgeries can be performed, but are not currently, because of the limitations of existing robotic platforms,” said Dvir Cohen, CEO and co-founder of Momentis Surgical.
“Anovo’s unique features allow surgeons and patients access to robotic procedures outside the hospital by offering robotic technology to ambulatory surgical centers.”
